Gesamt-, HDL- und LDL-Cholesterinbestimmung im Serum von Ratten- Vergleich einiger Methoden mit der UltrazentrifugationDifferent methods for the estimation of total cholesterol, HDL- and LDL-cholesterol were carried out in rat serum. Their applicability considering precision, accuracy, practicability ...
Gesamt‐, HDL‐ und LDL‐Cholesterinbestimmung im Serum von Ratten‐ Vergleich einiger Methoden mit der UltrazentrifugationDifferent methods for the estimation of total cholesterol, HDL- and LDL-cholesterol were carried out in rat serum. Their applicability considering precision, accuracy, ...
LDL: most patients had values below 165 mg/dl (one patient had 277). The index (quotient LDL/cholesterol) was found to be between 0.19 and 0.79. Group II: cholesterol 130 to 256 (arithmetic mean 207) mg/dl. Determination of -lipoprotein according to Watson gives higher values than by ...
THERAPEUTIC LIFESTYLE CHANGES, IN CONSULTATION WITH A REGISTERED DIETITIAN, REDUCES LDL-CHOLESTEROL AND INCREASES HDL-CHOLESTEROL IN PATIENTS WITH HYPERLIPIDEMIAdoi:10.1016/S0002-8223(08)70021-XM. Zeller RD, LDA. Dunn RD, LD, CDEK. Heinbeck Dietetic Intern...
LDL-Cholesterin...Traindl OVerlag Krause und Pachernegg GmbHJournal Für KardiologieTRAINDL, O. (2005): Was verursacht die KHK? LDL- oder HDL-Cholesterin. Journal fur Kardiologie 2005, 12 (Supplementum C), 10-11Traindl O. Was verursacht KHK? LDL- oder HDL-Cholesterin. J Kardiol 2005...
European Journal of PharmacologyDadgar H, Toghyani M, Dadgar M. Effect of dietary Blue-Green-Alga (Spirulina Platensis) as a food supplement on cholesterl, HDL, LDL cholesterol and triglyceride of broiler chicken. Eur J Pharmacol 2011; 6, 8-37....
Method of lowering lipid, triglyceride, total cholesterol and LDL-cholesterol serum levels and increasing the HDL/LDL cholesterol ratio thereby treating cardiovascular diseaseDescribed is a composition comprising (a) soy protein, (b) a phytoestrogen compound, and (c) dietary fibres. The soy protein ...
BENZOAZEPINE-OXY-ESSIC ACID DERIVATIVES AS PPAR-DELTA AGONISTS FOR INCREASING HDL-C, DECREASING LDL-C, AND CHOLESTERINE REDUCTIONThe invention is directed to compounds of Formula (I) useful as PPAR agonists. Pharmaceutical compositions and methods of treating one or more conditions including, but ...